AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CELLDEX THERAPEUTICS, INC. · Biotechnology company developing therapeutics for patients.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $90,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Issues related to mast cell conditions and therapies; Issues related to drug development and biopharma ecosystem.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.